|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,070.00 JPY | +1.24% |
|
+7.11% | +31.29% |
| 10/03 | Trial's Same-Store Sales Gain 2.1% in February | MT |
| 10/02 | Trial Holdings Inc. Reports Preliminary Sales Results for the Month and Year to Date Ended January 2026 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.41% | 0.41% | 147.14x | 3.16x | 0.55x | 11.87x | 26.26x | 308.91Cr | ||
| 0.54% | 0.58% | 49.36x | 12.49x | 1.46x | 30.47x | 37.44x | 45TCr | ||
| 3.38% | 3.81% | 19.01x | 4.48x | 1.02x | 10.02x | 13.19x | 5.51TCr | ||
| 3.95% | 3.94% | 14.82x | 3.1x | 0.62x | 7.95x | 12.98x | 5.31TCr | ||
| 0.22% | 0.25% | 41.46x | 35.37x | 8.03x | 24.43x | 30.1x | 3.87TCr | ||
| 1.8% | 1.84% | 20.12x | 3.4x | 0.78x | 10.47x | 15.58x | 2.9TCr | ||
| 0.85% | 0.96% | 26.74x | 4.33x | 1.34x | 14.45x | 18.3x | 1.89TCr | ||
| -.--% | -.--% | 28.12x | 3.53x | 2.43x | 17.86x | 21.65x | 670.06Cr | ||
| 4.39% | 4.82% | 16.2x | 0.55x | 0.57x | 8.37x | 16.87x | 511.46Cr | ||
| 1.71% | 1.89% | 13.32x | 5.05x | 1x | 5.14x | 10.47x | 406Cr | ||
| 5.26% | 5.67% | 9.2x | 2.16x | 0.69x | 5.63x | 9.46x | 238.14Cr | ||
| 1.75% | 1.86% | 19.79x | 2.89x | 0.88x | 8.69x | 10.96x | 166.89Cr | ||
| 3.15% | 3.15% | 9.32x | - | - | - | - | 5.26Cr | ||
| Average | 2.11% | 2.24% | 31.89x | 6.71x | 1.61x | 12.95x | 18.61x | 5.12TCr | |
| Weighted average by Cap. | 1.14% | 1.22% | 41.25x | 11.44x | 1.69x | 24.62x | 30.85x |
- Stock Market
- Equities
- 141A Stock
- Sector TRIAL Holdings, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















